Ascentage Pharma Group International

Common Name
Ascentage Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
605
Ticker
6855
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Ascentage Pharma Group International is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for cancer, hepatitis, and age-related dise...

Ascentage Pharma's Climate Target Data Preview

As of 2023, Ascentage Pharma has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Ascentage Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2040
Download Ascentage Pharma's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Ascentage Pharma’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ascentage Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ascentage Pharma's ESG Report 2023
Trace every data point back to Ascentage Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Ascentage Pharma's Greenhouse Gas Emissions Pathways

As of 2023, Ascentage Pharma has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a

Want Full Access to Ascentage Pharma's Climate Targets Dataset?
Sign Up